American Nutriceuticals - A0101 - Natura, 101-Respiratory

120 Vegicaps Natura 101 (Compound Jinqiaomai Granules) has been applied in the clinical treatment of more than 50,000 patients with lung cancer and has shown marked efficacy for more than a decade. In a clinical analysis using 1,000 of these patients, the effect of Natura 101 was examined. All patients underwent pathology, cytology and medical imaging examinations and were diagnosed as having lung cancer. Of the 1,000 participants, the number of basically cured was 181 cases (18.0%) with survival for at least 5 years; 518 cases (51.8%) were markedly effective; 204 cases (20.4%) were effective; 97 cases (9.7%) were ineffective; for a total effectiveness rate of 90.2%. When Natura 101 is used in lung cancer patients, there are no toxic adverse reactions, a marked effect in inhibiting the growth of tumor cells and an improvement of immunological function and quality of life. The below clinical synopsis reflects only liver cancer patients, but the 201 formula has also been used successfully for other digestive system cancers such as stomach, pancreas and intestine.